Integrated GP care for patients with persistent physical symptoms: feasibility cluster randomised trial

Patel, Meenal; James, Kirsty; Moss-Morris, Rona; Ashworth, Mark; Husain, Mujtaba; Hotopf, Matthew; David, Anthony S.; McCrone, Paul; Landau, Sabine; Chalder, Trudie

doi:10.1186/s12875-020-01269-9

BMC Primary Care

Table 5 Summaries of outcome variables by trial arm

From: Integrated GP care for patients with persistent physical symptoms: feasibility cluster randomised trial

Follow-up time point		12 weeks			24 weeks
Clinical scale		Intervention n = 89	Control n = 72	Overall n = 161	Intervention n = 89	Control n = 72	Overall n = 161
WSAS	N	75	66	141	78	62	140
WSAS	*mean (sd) [range]*	18.3 (11.5) [0.0, 40.0]	18.4 (11.0) [0.0, 39.0]	18.3 (11.3) [0.0, 40.0]	17.9 (11.7) [0.0, 40.0]	17.2 (12.6) [0.0, 40.0]	17.6 (12.0) [0.0, 40.0]
PHQ 15	N	74	63	137	77	62	139
PHQ 15	*mean (sd) [range]*	13.2 (5.9) [2.0, 26.5]	13.7 (5.6) [3.0, 27.0]	13.4 (5.8) [2.0, 27.0]	12.7 (5.7) [1.0, 27.7]	13.1 (5.6) [1.0, 23.1]	12.9 (5.7) [1.0, 27.7]
PHQ 9	N	75	64	139	78	62	140
PHQ 9	*mean (sd) [range]*	9.1 (6.4) [0.0, 25.0]	9.5 (6.2) [0.0, 26.0]	9.3 (6.3) [0.0, 26.0]	9.2 (6.4) [0.0, 27.0]	8.1 (5.9) [0.0, 24.0]	8.7 (6.2) [0.0, 27.0]
Below cut off	*n (%)*	19 (25.3)	16 (25.0)	35 (25.2)	21 (26.9)	22 (35.5)	43 (30.7)
Mild	*n (%)*	25 (33.3)	18 (28.1)	43 (30.9)	25 (32.1)	17 (27.4)	42 (30.0)
Moderate	*n (%)*	14 (18.7)	17 (26.6)	31 (22.3)	17 (21.8)	15 (24.2)	32 (22.9)
Moderately severe	*n (%)*	11 (14.7)	8 (12.5)	19 (13.7)	9 (11.5)	5 (8.1)	14 (10.0)
Severe	*n (%)*	6 (8.0)	5 (7.8)	11 (7.9)	6 (7.7)	3 (4.8)	9 (6.4)
CGI	N	76	67	143	79	63	142
CGI	*mean (sd) [range]*	4.9 (1.3) [2.0, 9.0]	4.8 (1.4) [1.0, 9.0]	4.8 (1.4) [1.0, 9.0]	4.8 (1.5) [2.0, 9.0]	4.7 (1.5) [2.0, 9.0]	4.8 (1.5) [2.0, 9.0]
CBRQ
Catastrophising	N	77	65	142	78	61	139
Catastrophising	*mean (sd) [range]*	8.7 (3.9) [0.0, 16.0]	9.4 (3.1) [3.0, 16.0]	9.0 (3.6) [0.0, 16.0]	8.6 (4.0) [0.0, 16.0]	8.8 (3.7) [0.0, 16.0]	8.7 (3.8) [0.0, 16.0]
Fear avoidance	N	77	65	142	76	59	135
Fear avoidance	*mean (sd) [range]*	10.4 (4.7) [0.0, 24.0]	10.6 (5.1) [0.0, 24.0]	10.5 (4.9) [0.0, 24.0]	10.3 (5.0) [1.0, 24.0]	10.1 (4.6) [1.0, 20.4]	10.2 (4.8) [1.0, 24.0]
Embarrassment avoidance	N	77	65	142	78	61	139
Embarrassment avoidance	*mean (sd) [range]*	10.5 (6.6) [0.0, 24.0]	10.7 (6.9) [0.0, 24.0]	10.6 (6.7) [0.0, 24.0]	10.3 (6.1) [0.0, 24.0]	9.7 (7.0) [0.0, 24.0]	10.0 (6.5) [0.0, 24.0]
Damage	N	76	65	141	76	59	135
Damage	*mean (sd) [range]*	10.1 (3.0) [4.0, 20.0]	10.6 (3.5) [2.0, 18.0]	10.3 (3.2) [2.0, 20.0]	9.8 (3.0) [1.0, 16.0]	10.2 (3.4) [4.0, 18.0]	10.0 (3.2) [1.0, 18.0]
Symptom Focusing	N	77	65	142	77	61	138
Symptom Focusing	*mean (sd) [range]*	13.8 (6.2) [0.0, 27.0]	14.5 (5.4) [2.0, 28.0]	14.1 (5.8) [0.0, 28.0]	13.5 (5.7) [2.0, 28.0]	13.5 (5.1) [2.0, 26.0]	13.5 (5.4) [2.0, 28.0]

WSAS Work and Social Adjustment Scale, PHQ-15 Patient Health Questionnaire 15, PHQ 9 Patient Health Questionnaire 9, CGI Clinical Global Impression, CBRQ Cognitive Behavioural Responses Questionnaire

Back to article page

ISSN: 2731-4553

Contact us

General enquiries: journalsubmissions@springernature.com